Longevity Health Holdings, Inc. Research And Development Expense

Quick Answer

Longevity Health Holdings, Inc. reported Research And Development Expense of $788.9 thousand for the year ending 2025.

  • Longevity Health Holdings, Inc. showed a decrease of -25.2% in Research And Development Expense from 2024 to 2025.
  • This data is from Longevity Health Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Longevity Health Holdings, Inc.'s Research And Development Expense has declined by 64.1%.
  • Historical annual values: Fiscal year 2025: $788.9 thousand | Fiscal year 2024: $1.05 million | Fiscal year 2023: $2.50 million | Fiscal year 2022: $2.20 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: